Year-end Sale % OFF 
Abstract
The adherence to therapy associated with the socio-demographic variables and the habits of patients with hypertension and/or diabetes mellitus were investigated in this study. The registration forms of 105 patients in the Hiperdia program in the municipality of Campina Grande-PB were used as a data collection instrument, applying the Morisky-Green test (MGT) and Batalla test (BT) to assess compliance treatment. For the MGT, there was a prevalence of non-adherent individuals (76.2%) and the type of predominant behavior was unintentional. The internal consistency of the responses obtained through the MGT presented good reliability, according to the value of 0.69 obtained by Cronbach’s alpha. For the BT, there was a predominance of adherence (68.6%) and the alpha value was 0.80, showing a high reliability level. It was found that a diet lacking in salt is a strong impact variable for determining the adherence to the BT. Given the representativity of the tests, there is a need to amend the interferences that facilitate the low adherence to drug treatment. The results of this study can be used to construct strategies that will address these difficulties and optimize the adherence level and quality of life of patients.
Highlights
The prevalence of hypertension and diabetes mellitus (DM) has increased worldwide, especially in lowand middle-income countries
Hypertension, and/or DM, it was observed that 81 participants (77.1%) had only hypertension, 4 (3.8%) had only diabetics, and 20 (19%) had both morbidities
We identified that a predominance of participants, a total of 62 (59.0%), possessed the hereditary factor for developing hypertension and/or DM
Summary
The prevalence of hypertension and diabetes mellitus (DM) has increased worldwide, especially in lowand middle-income countries. The World Health Organization (WHO, 2012) highlighted the growing problem of the increase in non-communicable diseases and showed that about 30% of the world population presents hypertension and 10% presents DM. In Brazil, hypertension presents itself as a serious public health problem due to its high prevalence, affecting between 15% and 20% of the adult population and more than 50% of the elderly (Carvalho Filha, Nogueira, Viana, 2011; Strelec, Pierin, Mion, 2011). As most of its course is asymptomatic, its diagnosis and treatment are often neglected; in addition, therapeutic adherence tends to be low, which results in an inadequate control of hypertension (Ministry of Health of Brazil, 2006). DM is one of the major public health diseases in Brazil.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
